TY - JOUR
T1 - Pancreatitis-associated protein-1 suppresses apoptosis in cerulein-stimulated pancreatic acinar cells in response to nuclear factor-kappa B activation
AU - Yu, J. H.
AU - Lim, J. W.
AU - Kim, Hyeyoung
N1 - Publisher Copyright:
© 2019, Polish Physiological Society. All rights reserved.
PY - 2019/12
Y1 - 2019/12
N2 - Pancreatitis is a disease for which there are numerous etiologies but no effective treatments. Although the expression of the pancreatitis-associated protein-1 (PAP-1) serves as a marker for the disease, its biological function is unknown. The present study was carried out to determine if PAP-1 performs a protective role against oxidative stress-induced pancreatic cell death. For this purpose, we used cerulein-stimulated pancreatic acinar AR42J cells as an experimental model of acute pancreatitis. First, we demonstrated that PAP-1 gene expression is increased by cerulein in a dose-and time-dependent manner. In parallel, the level of active nuclear factor kappaB (NF-kB) was found to be increased in cells treated with cerulein. To test whether activation of the oxidant-sensitive transcription factor NF-kB is mediated by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, the primary source of reactive oxygen species, cerulein-stimulated NADPH oxidase activity was suppressed by using the NADPH oxidase inhibitor diphenyleneiodonium and, separately, by anti-sense oligonucleotides directed against NADPH oxidase subunits p22phox and p47phox. We observed that a decrease in NADPH oxidase activity resulted in decreased NF-kB activation and decreased PAP-1 gene expression. To determine whether the cerulein-induced NF-kB activation involves PAP-1 expression, cells were transfected to overexpress the MAD3 double-point IkBa mutant. In response, NF-kB activation and PAP-1 gene expression were decreased. Lastly, we observed that the cerulein-induced reduction in cell viability and increase in apoptosis are reversed by overexpression of PAP-1 in PAP-1-transfected cells. Taken together, these results support the postulate that PAP-1 inhibits cerulein-induced apoptosis in response to NADPH oxidase-mediated NF-kB activation in pancreatic acinar cells.
AB - Pancreatitis is a disease for which there are numerous etiologies but no effective treatments. Although the expression of the pancreatitis-associated protein-1 (PAP-1) serves as a marker for the disease, its biological function is unknown. The present study was carried out to determine if PAP-1 performs a protective role against oxidative stress-induced pancreatic cell death. For this purpose, we used cerulein-stimulated pancreatic acinar AR42J cells as an experimental model of acute pancreatitis. First, we demonstrated that PAP-1 gene expression is increased by cerulein in a dose-and time-dependent manner. In parallel, the level of active nuclear factor kappaB (NF-kB) was found to be increased in cells treated with cerulein. To test whether activation of the oxidant-sensitive transcription factor NF-kB is mediated by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, the primary source of reactive oxygen species, cerulein-stimulated NADPH oxidase activity was suppressed by using the NADPH oxidase inhibitor diphenyleneiodonium and, separately, by anti-sense oligonucleotides directed against NADPH oxidase subunits p22phox and p47phox. We observed that a decrease in NADPH oxidase activity resulted in decreased NF-kB activation and decreased PAP-1 gene expression. To determine whether the cerulein-induced NF-kB activation involves PAP-1 expression, cells were transfected to overexpress the MAD3 double-point IkBa mutant. In response, NF-kB activation and PAP-1 gene expression were decreased. Lastly, we observed that the cerulein-induced reduction in cell viability and increase in apoptosis are reversed by overexpression of PAP-1 in PAP-1-transfected cells. Taken together, these results support the postulate that PAP-1 inhibits cerulein-induced apoptosis in response to NADPH oxidase-mediated NF-kB activation in pancreatic acinar cells.
UR - http://www.scopus.com/inward/record.url?scp=85079771629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079771629&partnerID=8YFLogxK
U2 - 10.26402/jpp.2019.6.04
DO - 10.26402/jpp.2019.6.04
M3 - Article
C2 - 32084646
AN - SCOPUS:85079771629
SN - 0867-5910
VL - 70
JO - Journal of Physiology and Pharmacology
JF - Journal of Physiology and Pharmacology
IS - 6
ER -